REQUEST A DEMO
Total
USD $0.00
Search more companies

Hk Inno.N Corporation (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hk Inno.N Corporation Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company mainly engaged in the manufacture and sale of prescription drugs. The Company operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The Company sells its products within domestic market and to overseas markets. The Company was established on April 1, 2014. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on August 9, 2021.

Headquarters
239, Osongsaengmyeong 2-Ro, Osong-Eup, Heungdeok-Gu
Cheongju; Chungcheongbuk;

Contact Details: Purchase the Hk Inno.N Corporation report to view the information.

Website: http://www.inno-n.com

Basic Information
Total Employees:
Purchase the Hk Inno.N Corporation report to view the information.
Outstanding Shares:
Purchase the Hk Inno.N Corporation report to view the information.
Registered Capital:
Purchase the Hk Inno.N Corporation report to view the information.
Financial Auditors:
Purchase the Hk Inno.N Corporation report to view the information.
Incorporation Date:
April 01, 2014
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
Kolmar Korea Holdings Co.,Ltd
Company Performance
Financial values in the chart are available after Hk Inno.N Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
10.96%
Total operating revenue
10.78%
Operating profit (EBIT)
96.35%
Net Profit (Loss) for the Period
59.12%
Total assets
4.82%
Total equity
3.94%
Operating Profit Margin (ROS)
4.1%
Net Profit Margin
1.96%
Return on Equity (ROE)
0.79%
Debt to Equity Ratio
-1.03%
Quick Ratio
-0.19%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?